1. Home
  2. CRBU vs BYND Comparison

CRBU vs BYND Comparison

Compare CRBU & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$0.54

Market Cap

138.3M

Sector

Health Care

ML Signal

HOLD

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$7.13

Market Cap

117.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
BYND
Founded
2011
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
138.3M
117.8M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
CRBU
BYND
Price
$0.54
$7.13
Analyst Decision
Buy
Sell
Analyst Count
6
3
Target Price
$5.75
★ $12.50
AVG Volume (30 Days)
★ 4.7M
1.1M
Earning Date
11-11-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
3.64
★ 24.69
EPS
N/A
★ N/A
Revenue
N/A
★ $275,496,000.00
Revenue This Year
$145.34
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.44
$0.40
52 Week High
$3.53
$15.47

Technical Indicators

Market Signals
Indicator
CRBU
BYND
Relative Strength Index (RSI) 24.76 40.71
Support Level $0.44 $0.63
Resistance Level $1.72 $12.52
Average True Range (ATR) 0.06 0.42
MACD 0.01 0.01
Stochastic Oscillator 12.28 40.94

Price Performance

Historical Comparison
CRBU
BYND

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: